Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.
2.

Adenosine Receptors Differentially Regulate the Expression of Regulators of G-Protein Signalling (RGS) 2, 3 and 4 in Astrocyte-Like Cells.

Eusemann TN, Willmroth F, Fiebich B, Biber K, van Calker D.

PLoS One. 2015 Aug 11;10(8):e0134934. doi: 10.1371/journal.pone.0134934. eCollection 2015.

3.

Sensitivity and kinetics of signal transmission at the first visual synapse differentially impact visually-guided behavior.

Sarria I, Pahlberg J, Cao Y, Kolesnikov AV, Kefalov VJ, Sampath AP, Martemyanov KA.

Elife. 2015 Apr 16;4:e06358. doi: 10.7554/eLife.06358.

4.

From attention to memory along the dorsal-ventral axis of the medial prefrontal cortex: some methodological considerations.

Cassaday HJ, Nelson AJ, Pezze MA.

Front Syst Neurosci. 2014 Sep 8;8:160. doi: 10.3389/fnsys.2014.00160. eCollection 2014. Review.

5.

Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI.

Sander CY, Hooker JM, Catana C, Normandin MD, Alpert NM, Knudsen GM, Vanduffel W, Rosen BR, Mandeville JB.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11169-74. doi: 10.1073/pnas.1220512110. Epub 2013 May 30.

6.

Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.

Lamberts JT, Smith CE, Li MH, Ingram SL, Neubig RR, Traynor JR.

J Neurosci. 2013 Mar 6;33(10):4369-77. doi: 10.1523/JNEUROSCI.5470-12.2013.

7.

Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.

Wang Q, Traynor JR.

Mol Pharmacol. 2013 Feb;83(2):512-20. doi: 10.1124/mol.112.081992. Epub 2012 Nov 29.

8.

Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system.

Hearing MC, Zink AN, Wickman K.

Rev Neurosci. 2012;23(4):325-51. doi: 10.1515/revneuro-2012-0045. Review.

9.

A finer tuning of G-protein signaling through regulated control of RGS proteins.

Kach J, Sethakorn N, Dulin NO.

Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H19-35. doi: 10.1152/ajpheart.00764.2011. Epub 2012 Apr 27. Review.

10.

Deletion of PLCB1 gene in schizophrenia-affected patients.

Lo Vasco VR, Cardinale G, Polonia P.

J Cell Mol Med. 2012 Apr;16(4):844-51. doi: 10.1111/j.1582-4934.2011.01363.x.

11.

μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.

Traynor J.

Drug Alcohol Depend. 2012 Mar 1;121(3):173-80. doi: 10.1016/j.drugalcdep.2011.10.027. Epub 2011 Nov 29. Review.

12.

Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction.

Roman DL, Traynor JR.

J Med Chem. 2011 Nov 10;54(21):7433-40. doi: 10.1021/jm101572n. Epub 2011 Sep 29. No abstract available.

13.

Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors.

Masuho I, Wakasugi-Masuho H, Posokhova EN, Patton JR, Martemyanov KA.

J Biol Chem. 2011 Jun 17;286(24):21806-13. doi: 10.1074/jbc.M111.241513. Epub 2011 Apr 21.

14.

A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, Zachariou V.

J Neurosci. 2011 Apr 13;31(15):5617-24. doi: 10.1523/JNEUROSCI.4146-10.2011. Erratum in: J Neurosci. 2011 May 18;31(20):7578. Psigfogeorgou, Kassi [corrected to Psifogeorgou, Kassi].

15.

Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing.

Nelson AJ, Thur KE, Marsden CA, Cassaday HJ.

J Psychopharmacol. 2011 Dec;25(12):1649-60. doi: 10.1177/0269881110389211. Epub 2011 Jan 24.

16.

Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.

Wang Q, Traynor JR.

J Biol Chem. 2011 Mar 11;286(10):7854-64. doi: 10.1074/jbc.M110.160911. Epub 2011 Jan 5.

17.

Activators of G-protein signaling 3: a drug addiction molecular gateway.

Bowers MS.

Behav Pharmacol. 2010 Sep;21(5-6):500-13. doi: 10.1097/FBP.0b013e32833dcfa5. Review.

18.

Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling.

Sjögren B, Neubig RR.

Mol Pharmacol. 2010 Oct;78(4):550-7. doi: 10.1124/mol.110.065219. Epub 2010 Jul 27. Review.

19.

Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins.

Blazer LL, Roman DL, Chung A, Larsen MJ, Greedy BM, Husbands SM, Neubig RR.

Mol Pharmacol. 2010 Sep;78(3):524-33. doi: 10.1124/mol.110.065128. Epub 2010 Jun 22.

20.

RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.

Talbot JN, Jutkiewicz EM, Graves SM, Clemans CF, Nicol MR, Mortensen RM, Huang X, Neubig RR, Traynor JR.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11086-91. doi: 10.1073/pnas.1000003107. Epub 2010 Jun 2.

Supplemental Content

Support Center